Literature DB >> 24263189

Crossing the endothelial barrier during metastasis.

Nicolas Reymond1, Bárbara Borda d'Água, Anne J Ridley.   

Abstract

During metastasis, cancer cells disseminate to other parts of the body by entering the bloodstream in a process that is called intravasation. They then extravasate at metastatic sites by attaching to endothelial cells that line blood vessels and crossing the vessel walls of tissues or organs. This Review describes how cancer cells cross the endothelial barrier during extravasation and how different receptors, signalling pathways and circulating cells such as leukocytes and platelets contribute to this process. Identification of the mechanisms that underlie cancer cell extravasation could lead to the development of new therapies to reduce metastasis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24263189     DOI: 10.1038/nrc3628

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  146 in total

1.  MUC1 mediates transendothelial migration in vitro by ligating endothelial cell ICAM-1.

Authors:  Jennifer J Rahn; Jeffrey W Chow; Garnet J Horne; Brian K Mah; Joanne T Emerman; Pat Hoffman; Judith C Hugh
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

2.  Tumor cell migration in three dimensions.

Authors:  Steven Hooper; John F Marshall; Erik Sahai
Journal:  Methods Enzymol       Date:  2006       Impact factor: 1.600

Review 3.  The chemokine system and cancer.

Authors:  Frances R Balkwill
Journal:  J Pathol       Date:  2011-11-23       Impact factor: 7.996

4.  Human neutrophils facilitate tumor cell transendothelial migration.

Authors:  Q D Wu; J H Wang; C Condron; D Bouchier-Hayes; H P Redmond
Journal:  Am J Physiol Cell Physiol       Date:  2001-04       Impact factor: 4.249

5.  Breast cancer cell-derived cytokines, macrophages and cell adhesion: implications for metastasis.

Authors:  Christine Eichbaum; Anne-Sophie Meyer; Ni Wang; Esther Bischofs; Andrea Steinborn; Thomas Bruckner; Pnina Brodt; Christof Sohn; Michael H R Eichbaum
Journal:  Anticancer Res       Date:  2011-10       Impact factor: 2.480

6.  CD44 cross-linking induces integrin-mediated adhesion and transendothelial migration in breast cancer cell line by up-regulation of LFA-1 (alpha L beta2) and VLA-4 (alpha4beta1).

Authors:  Hwai-Shi Wang; Ying Hung; Cheng-Hsi Su; Shu-Ting Peng; Yi-Jhih Guo; Mei-Chun Lai; Ching-Yi Liu; Jia-Wei Hsu
Journal:  Exp Cell Res       Date:  2004-11-26       Impact factor: 3.905

7.  Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis.

Authors:  Erik Sahai; Christopher J Marshall
Journal:  Nat Cell Biol       Date:  2003-08       Impact factor: 28.824

Review 8.  Microenvironmental regulation of metastasis.

Authors:  Johanna A Joyce; Jeffrey W Pollard
Journal:  Nat Rev Cancer       Date:  2008-03-12       Impact factor: 60.716

Review 9.  Molecular basis of metastasis.

Authors:  Anne C Chiang; Joan Massagué
Journal:  N Engl J Med       Date:  2008-12-25       Impact factor: 91.245

10.  Moesin orchestrates cortical polarity of melanoma tumour cells to initiate 3D invasion.

Authors:  Ana Estecha; Lorena Sánchez-Martín; Amaya Puig-Kröger; Rubén A Bartolomé; Joaquín Teixidó; Rafael Samaniego; Paloma Sánchez-Mateos
Journal:  J Cell Sci       Date:  2009-09-01       Impact factor: 5.285

View more
  305 in total

Review 1.  Recent insights into endothelial control of leukocyte extravasation.

Authors:  Peter L Hordijk
Journal:  Cell Mol Life Sci       Date:  2016-01-21       Impact factor: 9.261

Review 2.  Metastasis of circulating tumor cells: favorable soil or suitable biomechanics, or both?

Authors:  Ana Sofia Azevedo; Gautier Follain; Shankar Patthabhiraman; Sébastien Harlepp; Jacky G Goetz
Journal:  Cell Adh Migr       Date:  2015-08-27       Impact factor: 3.405

3.  Osthole inhibited TGF β-induced epithelial-mesenchymal transition (EMT) by suppressing NF-κB mediated Snail activation in lung cancer A549 cells.

Authors:  Haitao Feng; Jin-Jian Lu; Yitao Wang; Lixia Pei; Xiuping Chen
Journal:  Cell Adh Migr       Date:  2017-02-02       Impact factor: 3.405

Review 4.  Chemokine signaling in cancer-stroma communications.

Authors:  Arun J Singh; Joe W Gray
Journal:  J Cell Commun Signal       Date:  2021-06-04       Impact factor: 5.782

5.  Angiopellosis as an Alternative Mechanism of Cell Extravasation.

Authors:  Tyler A Allen; David Gracieux; Maliha Talib; Debra A Tokarz; M Taylor Hensley; Jhon Cores; Adam Vandergriff; Junnan Tang; James B M de Andrade; Phuong-Uyen Dinh; Jeffrey A Yoder; Ke Cheng
Journal:  Stem Cells       Date:  2016-07-21       Impact factor: 6.277

6.  Adapting coculture in vitro models of the blood-brain barrier for use in cancer research: maintaining an appropriate endothelial monolayer for the assessment of transendothelial migration.

Authors:  Elodie Vandenhaute; Aurore Drolez; Emmanuel Sevin; Fabien Gosselet; Caroline Mysiorek; Marie-Pierre Dehouck
Journal:  Lab Invest       Date:  2016-02-22       Impact factor: 5.662

7.  Inhibition of endothelial nitric oxide synthase decreases breast cancer cell MDA-MB-231 adhesion to intact microvessels under physiological flows.

Authors:  Lin Zhang; Min Zeng; Bingmei M Fu
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-04-08       Impact factor: 4.733

Review 8.  Revisiting the hallmarks of cancer.

Authors:  Yousef Ahmed Fouad; Carmen Aanei
Journal:  Am J Cancer Res       Date:  2017-05-01       Impact factor: 6.166

9.  Platelet integrin α6β1 controls lung metastasis through direct binding to cancer cell-derived ADAM9.

Authors:  Elmina Mammadova-Bach; Paola Zigrino; Camille Brucker; Catherine Bourdon; Monique Freund; Adèle De Arcangelis; Scott I Abrams; Gertaud Orend; Christian Gachet; Pierre Henri Mangin
Journal:  JCI Insight       Date:  2016-09-08

10.  Biomimetic on-a-chip platforms for studying cancer metastasis.

Authors:  Esak Lee; H-H Greco Song; Christopher S Chen
Journal:  Curr Opin Chem Eng       Date:  2015-12-18       Impact factor: 5.163

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.